Global Pharmatech 

$0.05
2
+$0+0% Wednesday 14:07

Statistics

Day High
0.05
Day Low
0.05
52W High
0.24
52W Low
0.05
Volume
2,115
Avg. Volume
35
Mkt Cap
20.76M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2006
Q4 2006
Q1 2007
Q2 2007
Q3 2007
Q4 2007
Q1 2008
-0.06
-0.04
-0.02
-0
Expected EPS
N/A
Actual EPS
-0.0039

Financials

-21.86%Profit Margin
Unprofitable
2021
2022
2023
2024
622,000Revenue
-136,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GBLP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a major player in the pharmaceutical industry, directly competing in several therapeutic areas that Global Pharmatech targets.
Merck
MRK
Mkt Cap214.76B
Merck operates globally in the pharmaceutical sector, offering innovative medicines and vaccines that compete with Global Pharmatech's products.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson offers a broad range of health care products. Its pharmaceutical division competes with Global Pharmatech in multiple drug categories.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline focuses on a wide array of pharmaceutical products, directly competing with Global Pharmatech in the areas of respiratory diseases and vaccines.
Novartis
NVS
Mkt Cap237.61B
Novartis is known for its innovative medicines and directly competes with Global Pharmatech in several key therapeutic areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in various therapeutic areas, including immunology and oncology, where Global Pharmatech also has significant investments.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb is a major pharmaceutical company that competes with Global Pharmatech in the fields of cancer and cardiovascular diseases.
Sanofi
SNY
Mkt Cap124.45B
Sanofi produces a range of pharmaceutical products that compete across several of the same therapeutic areas as Global Pharmatech.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company offers products in oncology, diabetes, and neurodegeneration, competing with Global Pharmatech's product lines.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is involved in the development and manufacturing of pharmaceutical products in areas like oncology, cardiovascular, renal, and metabolism, competing with Global Pharmatech.

About

Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.
Show more...
CEO
Meisheng Liao
Employees
217
Country
US
ISIN
US37945N1090

Listings

0 Comments

Share your thoughts

FAQ

What is Global Pharmatech stock price today?
The current price of GBLP is $0.05 USD — it has increased by +0% in the past 24 hours. Watch Global Pharmatech stock price performance more closely on the chart.
What is Global Pharmatech stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Global Pharmatech stocks are traded under the ticker GBLP.
Is Global Pharmatech stock price growing?
GBLP stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Global Pharmatech has showed a -28.55% decrease.
What is Global Pharmatech market cap?
Today Global Pharmatech has the market capitalization of 20.76M
What were Global Pharmatech earnings last quarter?
GBLP earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Global Pharmatech revenue for the last year?
Global Pharmatech revenue for the last year amounts to 622,000 USD.
What is Global Pharmatech net income for the last year?
GBLP net income for the last year is -136,000 USD.
How many employees does Global Pharmatech have?
As of April 04, 2026, the company has 217 employees.
In which sector is Global Pharmatech located?
Global Pharmatech operates in the Consumer Staples sector.
When did Global Pharmatech complete a stock split?
Global Pharmatech has not had any recent stock splits.
Where is Global Pharmatech headquartered?
Global Pharmatech is headquartered in Mong Kok, US.